Impact of bronchodilator use on the prevalence of COPD in population-based samples. - Wikidata - awgldk - TriplyDB

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

http://www.wikidata.org/entity/Q39798721

about

Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010 Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010 GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America.Asthma and chronic obstructive pulmonary disease Occurrence of COPD in Patients with Respiratory Allergy: A Clinico-Spirometric Evaluation in a Tertiary Hospital, Kolkata.FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study.Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.Forced expiratory volume in one second predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery: a retrospective cohort study.Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study Efficient screening for COPD using three steps: a cross-sectional study in Mexico City.Instability in the COPD diagnosis upon repeat testing vary with the definition of COPD.Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study.Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study A retrospective study of two populations to test a simple rule for spirometry.Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data.Can spirometric norms be set using pre- or post- bronchodilator test results in older people?Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome.Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes.Pulmonary arterial enlargement predicts long-term survival in COPD patients.Significant Bronchodilator Responsiveness and “Reversibility” in a Population Sample The accuracy of a handheld "disposable pneumotachograph device" in the spirometric diagnosis of airway obstruction in a Chinese population

P2860

Q23910517-0C01FC56-1322-46BC-978C-1490A1E3F340 Q23922840-64750716-95B6-4743-9D86-BA76EDA1CCDB Q28587875-F3AFBC77-85BC-4AD4-B624-CEADDE1D9E02 Q33637995-BE26D084-19B9-48F5-996C-E1203C5C154B Q33706788-85C08FF6-2D73-4D7F-A6D3-27483E29E917 Q33831857-54CA24EA-DDE6-4247-861B-1D86D3632357 Q34294340-9715310C-9043-4609-BB08-8469E45327C0 Q34374230-46C3EF40-7D4D-45DE-90C0-BDF26E6A979F Q34749627-FF893316-FCE6-4157-B61F-B04BC9C6C126 Q34923982-60634D29-A4FF-404B-A8A3-06C53F8C7526 Q35215922-A51763CA-820F-4369-B747-989DC522CC4A Q35220209-D262D4C9-8A26-47A3-B491-2E550B39FA7A Q35451346-DAB5F0E3-E016-43B5-9283-055C9B7BB276 Q35906564-DF16925D-AB8D-4D0C-8FAF-B8B3F32E912E Q35988214-4B8F6B2F-7504-4A03-8ADF-64BEA2833D7C Q36040501-FC112127-BA2B-4541-A3D3-2A816A2F7A8B Q36373826-21D97830-1B92-4996-8777-24D9D2E90E80 Q36604236-498693D9-6731-489F-9DA0-FF274327DD24 Q37177278-9118437F-2116-428D-8ED6-C9B28FDDA5D2 Q38078048-B05B2617-8FDB-48E4-80A7-679873CFCA2F Q38617511-5EEE8741-5483-4AEA-8FE8-432EAC598F74 Q49521857-AAFE04A2-8753-4592-881B-6FB70A985021 Q54940823-A86736F0-A1E7-4873-A77E-2EF0C3B1E879 Q58061937-B6A547B8-6A07-4A4B-9B9D-4D8C26B06A14 Q58803501-E9601C36-08D9-4ABD-8AE2-A465C8A08401

P2860

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

http://www.wikidata.org/entity/Q39798721

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@en

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@nl

type

label

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@en

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@nl

prefLabel

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@en

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@nl

P1433

Q39798721-96B5E40D-BC93-49BE-96AA-EC4F3CBDCEC7

P1476

Q39798721-D85369AE-1957-4ED2-9169-98283C910F55

P2093

Q39798721-1FA11C63-F493-415B-BAA9-97747B7D49AF

Q39798721-2D1A4270-8EB8-47A9-9767-F628586D9F6C

Q39798721-304F2F9B-5F88-4F0B-91F1-ABCE32A4D7F0

Q39798721-4E2A6A6F-1256-4629-A72B-DE05719355F5

Q39798721-642C5A29-E811-4403-8C58-83CF4AB8FBE8

Q39798721-728BE255-A421-4E9C-8B70-04E880C6559F

Q39798721-7B41CFF2-F6F9-4484-A9B0-F83E79CD6198

Q39798721-8E5FBD17-6C60-4DF0-9EDC-529760BD648B

Q39798721-99F659F9-B420-4607-A211-3348010632DA

Q39798721-AB9A3B55-A011-47D4-9F99-97EC340DE514

P2860

Q39798721-02410AC3-03C5-42F7-9F0C-DF76EA0FA41D

Q39798721-0901A80F-C930-47C2-B5C5-94B793295390

Q39798721-0AB610B0-08EC-4F8F-88F1-D3A39D5F4399

Q39798721-0FD51A76-7AFE-45C8-BB5C-5477C28913C5

Q39798721-2A5B89C9-4785-47E5-B716-7599057E94D7

Q39798721-373C534C-1B0E-41F2-9EC2-52A200C49DBA

Q39798721-399A82AB-E5B0-4B4A-ABC6-801486B5AB1A

Q39798721-3B12301D-CCF0-4237-AAA5-6E9D1420AF1D

Q39798721-3F045E52-FE78-4D62-B2D2-9668778CC1B6

Q39798721-4CE1B515-0499-4827-B934-586AA65AA857

P304

Q39798721-C2DD002D-C545-4B8D-8E94-1AD02D0E9AA8

P31

Q39798721-4FB22FDC-0B6E-4A83-8E40-5303B73A8E6C

P356

Q39798721-220F21DF-4B50-4E67-AA72-D96C75455164

P407

Q39798721-8AB01B9B-D43B-48AF-85F6-269CF2A64A8C

P433

Q39798721-1C440EEF-2EB9-426B-87D5-669FBA52BA9F

P478

Q39798721-A22A2CA7-5FB4-4FD4-8D02-9377FBC3E57B

P577

Q39798721-785DF052-39FE-43F4-BDC1-66039AF931FB

P5875

Q39798721-B46F65D4-B9A2-4349-9E6D-32182A712F18

P698

Q39798721-0851344C-0A6E-4FB5-ADF0-7F442847208D

P356

15412550701341012

P1433

COPD: Journal of Chronic Obstructive Pulmonary Disease

P1476

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

@en

P2093

Adriana Muiño

http://www.w3.org/2001/XMLSchema#string

Ana Maria B Menezes

http://www.w3.org/2001/XMLSchema#string

Carlos Tálamo

http://www.w3.org/2001/XMLSchema#string

Gonzalo Valdivia

http://www.w3.org/2001/XMLSchema#string

Jose Jardim

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Vázquez-García

http://www.w3.org/2001/XMLSchema#string

Julio Pertuzé

http://www.w3.org/2001/XMLSchema#string

María Montes de Oca

http://www.w3.org/2001/XMLSchema#string

María Máquez

http://www.w3.org/2001/XMLSchema#string

María Victorina López

http://www.w3.org/2001/XMLSchema#string

P2860

Case definitions for chronic obstructive pulmonary disease

Spirometric reference values from a sample of the general U.S. population

The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities

Interpretative strategies for lung function tests

Standardisation of spirometry

Standardization of Spirometry, 1994 Update. American Thoracic Society

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation.

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15412550701341012

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6304268

http://www.w3.org/2001/XMLSchema#string

P698

17530504

http://www.w3.org/2001/XMLSchema#string